Position in UNCY
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$286,877
-$1,271,536 QoQ
Shares Held
61,168
-74.2% QoQ
Ownership
0.220%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#30
of 80 holders
Holding Since
Mar 2022
8 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in UNCY Over Time
Shares Held
Position Value (USD)
Derivatives in UNCY
reported options exposure · as of Jun 30, 2026CallValue
$433,825
CallShares
92,500
PutValue
$692,713
PutShares
147,700
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Biotechnology
Healthcare · as of Jun 30, 2026CITADEL ADVISORS LLC holds $6,086,778,995 across 435 Biotechnology names. UNCY ranks #296 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ONC |
BeOne Medicines Ltd.
|
1,425,517 | $406,229,578 | |
| 2 | BBIO |
BridgeBio Pharma, Inc.
|
3,760,028 | $280,046,885 | |
| 3 | INSM |
INSMED Inc
|
2,556,973 | $272,624,460 | |
| 4 | MDGL |
Madrigal Pharmaceuticals, Inc.
|
507,233 | $272,358,759 | |
| 5 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
510,430 | $253,545,893 | |
| 6 | JAZZ |
Jazz Pharmaceuticals plc
|
1,006,676 | $242,578,715 | |
| 7 | MANE |
Veradermics, Inc
|
1,877,775 | $230,853,658 | |
| 8 | ROIV |
Roivant Sciences Ltd.
|
5,576,261 | $197,343,876 |
All Filings in UNCY
Export CSV
13 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $286,877 | 61,168 | Shares | Defined | 2026-08-14 | |
| 2026-06-30 | $433,825 | 92,500 | Call | Defined | 2026-08-14 | |
| 2026-06-30 | $692,713 | 147,700 | Put | Defined | 2026-08-14 | |
| 2026-03-31 | $1,558,413 | 236,841 | Shares | Defined | 2026-05-15 | |
| 2026-03-31 | $167,132 | 25,400 | Call | Defined | 2026-05-15 | |
| 2026-03-31 | $542,850 | 82,500 | Put | Defined | 2026-05-15 | |
| 2025-12-31 | $1,490,396 | 258,301 | Shares | Defined | 2026-02-17 | |
| 2025-12-31 | $62,893 | 10,900 | Call | Defined | 2026-02-17 | |
| 2025-09-30 | $181,698 | 41,674 | Shares | Defined | 2025-11-14 | |
| 2024-03-31 | $95,765 | 69,395 | Shares | Defined | 2024-05-15 | |
| 2023-12-31 | $30,744 | 35,420 | Shares | Defined | 2024-02-14 | |
| 2022-06-30 | $12,623 | 15,210 | Shares | Defined | 2022-08-15 | |
| 2022-03-31 | $47,982 | 37,196 | Shares | Defined | 2022-05-16 | |
| No filing history on record for this holder in this stock. | ||||||